Experimental vaccine skin cancer from december to get
Photo: Hollandse Hoogte
From 1 december, hundreds of huidkankerpatiënten successfully treated an experimental vaccine to minimize the chance that the cancer comes back, is expected to be reduced.
The Radboudumc begins with a broad experimental treatment that enables the immune system of patients is activated against the cancer to return.
The therapy is intended for huidkankerpatiënten who recently lymph nodes with metastases are removed. In the study, 210 patients participate.
At the same time, other patients who are treatment-eligible would come to the same resources as a basic treatment. Not only research participants but also others would therefore be of benefit.
In the Netherlands there are annually an estimated three hundred people who, because of their disease, would have been eligible for the vaccine, told a spokesman of the Radboudumc Sunday.